Literature DB >> 33738063

Design and Structure-Activity Relationship of a Potent Furin Inhibitor Derived from Influenza Hemagglutinin.

Monika A Lewandowska-Goch1, Anna Kwiatkowska2,3, Teresa Łepek1, Kévin Ly4, Pauline Navals2,5,3, Hugo Gagnon4, Yves L Dory2,5, Adam Prahl1, Robert Day2,3.   

Abstract

Furin plays an important role in various pathological states, especially in bacterial and viral infections. A detailed understanding of the structural requirements for inhibitors targeting this enzyme is crucial to develop new therapeutic strategies in infectious diseases, including an urgent unmet need for SARS-CoV-2 infection. Previously, we have identified a potent furin inhibitor, peptide Ac-RARRRKKRT-NH 2 (CF1), based on the highly pathogenic avian influenza hemagglutinin. The goal of this study was to determine how its N-terminal part (the P8-P5 positions) affects its activity profile. To do so, the positional-scanning libraries of individual peptides modified at the selected positions with natural amino acids were generated. Subsequently, the best substitutions were combined together and/or replaced by unnatural residues to expand our investigations. The results reveal that the affinity of CF1 can be improved (2-2.5-fold) by substituting its P5 position with the small hydrophobic residues (Ile or Val) or a basic Lys.
© 2021 American Chemical Society.

Entities:  

Year:  2021        PMID: 33738063      PMCID: PMC7957945          DOI: 10.1021/acsmedchemlett.0c00386

Source DB:  PubMed          Journal:  ACS Med Chem Lett        ISSN: 1948-5875            Impact factor:   4.345


  34 in total

1.  A furin-like convertase mediates propeptide cleavage of BACE, the Alzheimer's beta -secretase.

Authors:  B D Bennett; P Denis; M Haniu; D B Teplow; S Kahn; J C Louis; M Citron; R Vassar
Journal:  J Biol Chem       Date:  2000-12-01       Impact factor: 5.157

2.  X-ray Structures of the Proprotein Convertase Furin Bound with Substrate Analogue Inhibitors Reveal Substrate Specificity Determinants beyond the S4 Pocket.

Authors:  Sven O Dahms; Kornelia Hardes; Torsten Steinmetzer; Manuel E Than
Journal:  Biochemistry       Date:  2018-01-26       Impact factor: 3.162

3.  Optimization of furin inhibitors to protect against the activation of influenza hemagglutinin H5 and Shiga toxin.

Authors:  Hugo Gagnon; Sophie Beauchemin; Anna Kwiatkowska; Frédéric Couture; François D'Anjou; Christine Levesque; Frédérik Dufour; Adamy Roberge Desbiens; Rolland Vaillancourt; Sylvain Bernard; Roxane Desjardins; François Malouin; Yves L Dory; Robert Day
Journal:  J Med Chem       Date:  2013-12-23       Impact factor: 7.446

4.  Novel Furin Inhibitors with Potent Anti-infectious Activity.

Authors:  Kornelia Hardes; Gero L Becker; Yinghui Lu; Sven O Dahms; Susanne Köhler; Wolfgang Beyer; Kirsten Sandvig; Hiroyuki Yamamoto; Iris Lindberg; Lisa Walz; Veronika von Messling; Manuel E Than; Wolfgang Garten; Torsten Steinmetzer
Journal:  ChemMedChem       Date:  2015-05-14       Impact factor: 3.466

5.  Design, synthesis, and structure-activity relationship studies of a potent PACE4 inhibitor.

Authors:  Anna Kwiatkowska; Frédéric Couture; Christine Levesque; Kévin Ly; Roxane Desjardins; Sophie Beauchemin; Adam Prahl; Bernard Lammek; Witold Neugebauer; Yves L Dory; Robert Day
Journal:  J Med Chem       Date:  2013-12-18       Impact factor: 7.446

6.  Positional Scanning Identifies the Molecular Determinants of a High Affinity Multi-Leucine Inhibitor for Furin and PACE4.

Authors:  Izabela Małuch; Christine Levesque; Anna Kwiatkowska; Frédéric Couture; Kévin Ly; Roxane Desjardins; Witold A Neugebauer; Adam Prahl; Robert Day
Journal:  J Med Chem       Date:  2017-03-24       Impact factor: 7.446

7.  Selective and potent furin inhibitors protect cells from anthrax without significant toxicity.

Authors:  Albert G Remacle; Katarzyna Gawlik; Vladislav S Golubkov; Gregory W Cadwell; Robert C Liddington; Piotr Cieplak; Sherri Z Millis; Roxane Desjardins; Sophie Routhier; Xue Wen Yuan; Witold A Neugebauer; Robert Day; Alex Y Strongin
Journal:  Int J Biochem Cell Biol       Date:  2010-03-01       Impact factor: 5.085

8.  Proprotein convertase models based on the crystal structures of furin and kexin: explanation of their specificity.

Authors:  Stefan Henrich; Iris Lindberg; Wolfram Bode; Manuel E Than
Journal:  J Mol Biol       Date:  2005-01-14       Impact factor: 5.469

9.  Design, Synthesis, and Characterization of Macrocyclic Inhibitors of the Proprotein Convertase Furin.

Authors:  Thuy Van Lam van; Teodora Ivanova; Kornelia Hardes; Miriam Ruth Heindl; Rory E Morty; Eva Böttcher-Friebertshäuser; Iris Lindberg; Manuel E Than; Sven O Dahms; Torsten Steinmetzer
Journal:  ChemMedChem       Date:  2019-02-20       Impact factor: 3.466

10.  alpha1-Antitrypsin Portland, a bioengineered serpin highly selective for furin: application as an antipathogenic agent.

Authors:  F Jean; K Stella; L Thomas; G Liu; Y Xiang; A J Reason; G Thomas
Journal:  Proc Natl Acad Sci U S A       Date:  1998-06-23       Impact factor: 12.779

View more
  2 in total

Review 1.  The Path to Therapeutic Furin Inhibitors: From Yeast Pheromones to SARS-CoV-2.

Authors:  Gary Thomas; Frédéric Couture; Anna Kwiatkowska
Journal:  Int J Mol Sci       Date:  2022-03-22       Impact factor: 6.208

Review 2.  Why All the Fury over Furin?

Authors:  Essam Eldin A Osman; Alnawaz Rehemtulla; Nouri Neamati
Journal:  J Med Chem       Date:  2021-08-02       Impact factor: 7.446

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.